172 related articles for article (PubMed ID: 33650203)
21. Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4
Wei G; Cao J; Huang P; An P; Badlani D; Vaid KA; Zhao S; Wang DQ; Zhuo J; Yin L; Frassetto A; Markel A; Presnyak V; Gandham S; Hua S; Lukacs C; Finn PF; Giangrande PH; Martini PGV; Popov YV
J Hepatol; 2021 Jun; 74(6):1416-1428. PubMed ID: 33340584
[TBL] [Abstract][Full Text] [Related]
22. Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein).
Oude Elferink RP; Paulusma CC
Pflugers Arch; 2007 Feb; 453(5):601-10. PubMed ID: 16622704
[TBL] [Abstract][Full Text] [Related]
23. Altered expression and function of canalicular transporters during early development of cholestatic liver injury in Abcb4-deficient mice.
Cai SY; Mennone A; Soroka CJ; Boyer JL
Am J Physiol Gastrointest Liver Physiol; 2014 Apr; 306(8):G670-6. PubMed ID: 24481602
[TBL] [Abstract][Full Text] [Related]
24. Case report: progressive familial intrahepatic cholestasis type 3 with compound heterozygous ABCB4 variants diagnosed 15 years after liver transplantation.
Goubran M; Aderibigbe A; Jacquemin E; Guettier C; Girgis S; Bain V; Mason AL
BMC Med Genet; 2020 Nov; 21(1):238. PubMed ID: 33256620
[TBL] [Abstract][Full Text] [Related]
25. ABCB4 disease: Many faces of one gene deficiency.
Sticova E; Jirsa M
Ann Hepatol; 2020; 19(2):126-133. PubMed ID: 31759867
[TBL] [Abstract][Full Text] [Related]
26. Functional characterization of ABCB4 mutations found in progressive familial intrahepatic cholestasis type 3.
Park HJ; Kim TH; Kim SW; Noh SH; Cho KJ; Choi C; Kwon EY; Choi YJ; Gee HY; Choi JH
Sci Rep; 2016 Jun; 6():26872. PubMed ID: 27256251
[TBL] [Abstract][Full Text] [Related]
27. Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene.
Wasmuth HE; Glantz A; Keppeler H; Simon E; Bartz C; Rath W; Mattsson LA; Marschall HU; Lammert F
Gut; 2007 Feb; 56(2):265-70. PubMed ID: 16891356
[TBL] [Abstract][Full Text] [Related]
28. ABCB4 missense mutations D243A, K435T, G535D, I490T, R545C, and S978P significantly impair the lipid floppase and likely predispose to secondary pathologies in the human population.
Andress EJ; Nicolaou M; McGeoghan F; Linton KJ
Cell Mol Life Sci; 2017 Jul; 74(13):2513-2524. PubMed ID: 28220208
[TBL] [Abstract][Full Text] [Related]
29. Complementary functions of the flippase ATP8B1 and the floppase ABCB4 in maintaining canalicular membrane integrity.
Groen A; Romero MR; Kunne C; Hoosdally SJ; Dixon PH; Wooding C; Williamson C; Seppen J; Van den Oever K; Mok KS; Paulusma CC; Linton KJ; Oude Elferink RP
Gastroenterology; 2011 Nov; 141(5):1927-37.e1-4. PubMed ID: 21820390
[TBL] [Abstract][Full Text] [Related]
30. Progressive familial intrahepatic cholestasis.
Srivastava A
J Clin Exp Hepatol; 2014 Mar; 4(1):25-36. PubMed ID: 25755532
[TBL] [Abstract][Full Text] [Related]
31. Case series of progressive familial intrahepatic cholestasis type 3: Characterization of variants in
Cheng J; Gong L; Mi X; Wu X; Zheng J; Yang W
Front Med (Lausanne); 2022; 9():962408. PubMed ID: 36569137
[TBL] [Abstract][Full Text] [Related]
32. ABCB4 disease mimicking morbus Wilson: A potential diagnostic pitfall.
Sticova E; Neroldova M; Kotalova R; Subhanova I; Jirsa M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):121-125. PubMed ID: 31728073
[TBL] [Abstract][Full Text] [Related]
33. Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing.
Vitale G; Gitto S; Raimondi F; Mattiaccio A; Mantovani V; Vukotic R; D'Errico A; Seri M; Russell RB; Andreone P
J Gastroenterol; 2018 Aug; 53(8):945-958. PubMed ID: 29238877
[TBL] [Abstract][Full Text] [Related]
34. Current and future therapies for inherited cholestatic liver diseases.
van der Woerd WL; Houwen RH; van de Graaf SF
World J Gastroenterol; 2017 Feb; 23(5):763-775. PubMed ID: 28223721
[TBL] [Abstract][Full Text] [Related]
35. Genetic Analysis of
Wang HH; Portincasa P; Liu M; Wang DQ
Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741809
[TBL] [Abstract][Full Text] [Related]
36. Canalicular ABC transporters and liver disease.
Nicolaou M; Andress EJ; Zolnerciks JK; Dixon PH; Williamson C; Linton KJ
J Pathol; 2012 Jan; 226(2):300-15. PubMed ID: 21984474
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanisms for biliary phospholipid and drug efflux mediated by ABCB4 and bile salts.
Morita SY; Terada T
Biomed Res Int; 2014; 2014():954781. PubMed ID: 25133187
[TBL] [Abstract][Full Text] [Related]
38. Thyroid hormone receptor β1 stimulates
Gautherot J; Claudel T; Cuperus F; Fuchs CD; Falguières T; Trauner M
J Lipid Res; 2018 Sep; 59(9):1610-1619. PubMed ID: 29895698
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylation of ABCB4 impacts its function: insights from disease-causing mutations.
Gautherot J; Delautier D; Maubert MA; Aït-Slimane T; Bolbach G; Delaunay JL; Durand-Schneider AM; Firrincieli D; Barbu V; Chignard N; Housset C; Maurice M; Falguières T
Hepatology; 2014 Aug; 60(2):610-21. PubMed ID: 24723470
[TBL] [Abstract][Full Text] [Related]
40. Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors.
Amico G; Brandas C; Moran O; Baroni D
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
